학술논문
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Research in context
Document Type
article
Author
Jon Salmanton-García; Francesco Marchesi; Francesca Farina; Barbora Weinbergerová; Federico Itri; Julio Dávila-Valls; Sonia Martín-Pérez; Andreas Glenthøj; Ditte Stampe Hersby; Maria Gomes da Silva; Raquel Nunes Rodrigues; Alberto López-García; Raúl Córdoba; Yavuz M. Bilgin; Iker Falces-Romero; Shaimaa El-Ashwah; Ziad Emarah; Caroline Besson; Milena Kohn; Jaap Van Doesum; Emanuele Ammatuna; Monia Marchetti; Jorge Labrador; Giovanni Paolo Maria Zambrotta; Luisa Verga; Ozren Jaksic; Marcio Nucci; Klára Piukovics; Alba Cabirta-Touzón; Moraima Jiménez; Elena Arellano; Ildefonso Espigado; Ola Blennow; Anna Nordlander; Stef Meers; Jens van Praet; Tommaso Francesco Aiello; Carolina Garcia-Vidal; Nicola Fracchiolla; Mariarita Sciumè; Guldane Cengiz Seval; Pavel Žák; Caterina Buquicchio; Carlo Tascini; Stefanie K. Gräfe; Martin Schönlein; Tatjana Adžić-Vukičević; Valentina Bonuomo; Chiara Cattaneo; Summiya Nizamuddin; Martin Čerňan; Gaëtan Plantefeve; Romane Prin; Tomas Szotkovski; Graham P. Collins; Michelina Dargenio; Verena Petzer; Dominik Wolf; Natasha Čolović; Lucia Prezioso; Toni Valković; Francesco Passamonti; Gustavo-Adolfo Méndez; Uluhan Sili; Antonio Vena; Martina Bavastro; Alessandro Limongelli; Rafael F. Duarte; Marie-Pierre Ledoux; Milche Cvetanoski; Zlate Stojanoski; Marina Machado; Josip Batinić; Gabriele Magliano; Monika M. Biernat; Nikola Pantić; Christian Bjørn Poulsen; Annarosa Cuccaro; Maria Ilaria Del Principe; Austin Kulasekararaj; Irati Ormazabal-Vélez; Alessandro Busca; Fatih Demirkan; Marriyam Ijaz; Nikolai Klimko; Igor Stoma; Sofya Khostelidi; Noemí Fernández; Ali S. Omrani; Rui Bergantim; Nick De Jonge; Guillemette Fouquet; Milan Navrátil; Ghaith Abu-Zeinah; Michail Samarkos; Johan Maertens; Cristina De Ramón; Anna Guidetti; Ferenc Magyari; Tomás José González-López; Tobias Lahmer; Olimpia Finizio; Natasha Ali; László Imre Pinczés; Esperanza Lavilla-Rubira; Alessandra Romano; Maria Merelli; Mario Delia; Maria Calbacho; Joseph Meletiadis; Darko Antić; José-Ángel Hernández-Rivas; Joyce Marques de Almeida; Murtadha Al-Khabori; Martin Hoenigl; Maria Chiara Tisi; Nina Khanna; Aleksandra Barać; Noha Eisa; Roberta Di Blasi; Raphaël Liévin; Carolina Miranda-Castillo; Nathan C. Bahr; Sylvain Lamure; Mario Virgilio Papa; Ayel Yahya; Avinash Aujayeb; Jan Novák; Nurettin Erben; María Fernández-Galán; José-María Ribera-Santa Susana; Ikhwan Rinaldi; Rita Fazzi; Monica Piedimonte; Rémy Duléry; Yung Gonzaga; Andrés Soto-Silva; Giuseppe Sapienza; Alexandra Serris; Ľuboš Drgoňa; Ana Groh; Laura Serrano; Eleni Gavriilaki; Athanasios Tragiannidis; Juergen Prattes; Nicola Coppola; Vladimir Otašević; Miloš Mladenović; Mirjana Mitrović; Bojana Mišković; Pavel Jindra; Sofia Zompi; Maria Vittoria Sacchi; Carolin Krekeler; Maria Stefania Infante; Daniel García-Bordallo; Gökçe Melis Çolak; Jiří Mayer; Marietta Nygaard; Michaela Hanáková; Zdeněk Ráčil; Matteo Bonanni; Philipp Koehler; Laman Rahimli; Oliver A. Cornely; Livio Pagano; Francisco Javier Martín-Vallejo; Przemyslaw Zdziarski; Hossein Zarrinfer; Jana Wittig; Sein Win; Vivien Wai-Man; Benjamín Víšek; Donald C. Vinh; Maria Vehreschild; Gina Varricchio; Panagiotis Tsirigotis; Ana Torres-Tienza; Alina Daniela Tanase; Agostino Tafuri; Maria Stamouli; Jiří Sramek; Carole Soussain; Ayten Shirinova; Jörg Schubert; Enrico Schalk; Mohammad Reza Salehi; Modar Saleh; Giorgio Rosati; Elisa Roldán; Florian Reizine; Mayara Rêgo; Isabel Regalado-Artamendi; Marina Popova; Fernando Pinto; Laure Philippe; Hans Martin Orth; Hans-Beier Ommen; Aleš Obr; Lucía Núñez-Martín-Buitrago; Nicolas Noël; Julia Neuhann; Gianpaolo Nadali; Julia A. Nacov; Ana M. Munhoz Alburquerque; Maria Enza Mitra; Malgorzata Mikulska; Sibylle Mellinghoff; Ben Mechtel; Juan-Alberto Martín-González; Sandra Malak; Jorge Loureiro-Amigo; Lisset Lorenzo De La Peña; Giulia Liberti; Marianne Landau; Ira Lacej; Martin Kolditz; Chi Shan Kho; Reham Abdelaziz Khedr; Meinolf Karthaus; Linda Katharina Karlsson; María-Josefa Jiménez-Lorenzo; Macarena Izuzquiza; Baerbel Hoell-Neugebauer; Raoul Herbrecht; Christopher H. Heath; Fabio Guolo; Jan Grothe; Antonio Giordano; Sergey Gerasymchuk; Ramón García-Sanz; Nicole García-Poutón; Vaneuza Araújo Moreira Funke; Monica Fung; Charlotte Flasshove; Luana Fianchi; Jenna Essame; Matthias Egger; Bernard Drenou; Giulia Dragonetti; Maximilian Desole; Roberta Della Pepa; Bénédicte Deau Fischer; Elizabeth De Kort; Erik De Cabo; François Danion; Etienne Daguindau; Tania Cushion; Louise Cremer; Marianna Criscuolo; Gregorio Cordini; Antonella Cingolani; Fabio Ciceri; Fazle Rabbi Chowdhury; Ekaterina Chelysheva; Adrien Chauchet; Louis Yi Ann Chai; M. Mansour Ceesay; Elena Busch; Mathias Brehon; Davimar M.M. Borducchi; Stephen Booth; Serge Bologna; Caroline Berg Venemyr; Rebeca Bailén-Almorox; Anastasia Antoniadou; Amalia N. Anastasopoulou; Fevzi Altuntaş
Source
EClinicalMedicine, Vol 71, Iss , Pp 102553- (2024)
Subject
Language
English
ISSN
2589-5370
Abstract
Summary: Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced. Methods: The EPICOVIDEHA registry (National Clinical Trials Identifier, NCT04733729) gathers COVID-19 data from hematological malignancy patients since the pandemic's start worldwide. It spans various global locations, allowing comprehensive analysis over the first three years (2020–2022). Findings: The EPICOVIDEHA registry collected data from January 2020 to December 2022, involving 8767 COVID-19 cases in hematological malignancy patients from 152 centers across 41 countries, with 42% being female. Over this period, there was a significant reduction in critical infections and an overall decrease in mortality from 29% to 4%. However, hospitalization, particularly in the ICU, remained associated with higher mortality rates. Factors contributing to increased mortality included age, multiple comorbidities, active malignancy at COVID-19 onset, pulmonary symptoms, and hospitalization. On the positive side, vaccination with one to two doses or three or more doses, as well as encountering COVID-19 in 2022, were associated with improved survival. Interpretation: Patients with hematological malignancies still face elevated risks, despite reductions in critical infections and overall mortality rates over time. Hospitalization, especially in ICUs, remains a significant concern. The study underscores the importance of vaccination and the timing of COVID-19 exposure in 2022 for enhanced survival in this patient group. Ongoing monitoring and targeted interventions are essential to support this vulnerable population, emphasizing the critical role of timely diagnosis and prompt treatment in preventing severe COVID-19 cases. Funding: Not applicable.